Skip to main content
M

METABIOMED.CO.,LTD — Investor Relations & Filings

Ticker · 059210 ISIN · KR7059210005 KO Manufacturing
Open in API
Filings indexed 210 across all filing types
Latest filing 2026-04-27 Director's Dealing
Country KR South Korea
Listing KO 059210

About METABIOMED.CO.,LTD

https://www.meta-biomed.com/

METABIOMED.CO.,LTD. is a developer and manufacturer of medical devices and biomaterials. The company's operations are organized into four primary business areas: Dental, Suture Material & Biomaterial, Meta Surgical, and Cosmetic Medical. Its dental division provides a range of equipment and materials, with its root canal filling product holding the largest global market share. The company also manufactures various synthetic absorbable surgical sutures, including Poliglecaprone (PGCL) and Polydioxanone (PDO) types. The surgical division offers devices for use in general surgery, orthopedics, neurosurgery, and obstetrics & gynecology. In the cosmetic medical field, it produces products such as PDO threads. METABIOMED distributes its products to over 100 countries through a global sales network.

Recent filings

Filing Released Lang Actions
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a regulatory disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (“Report on holdings of specific securities by executives and major shareholders”) containing detailed insider transaction data, acquisition dates, share counts, and correction of previously filed data. This aligns with insider trading disclosure by company directors/executives. It is not a financial statement, earnings release, or annual/interim report, nor a simple publication announcement. Therefore, it fits the “Director's Dealing” category.
2026-04-27 Korean
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a regulatory filing detailing an executive’s (director’s) personal ownership of company securities, including corrected share totals and transaction details (acquisitions on specific dates). This aligns with an insider transaction report by a company director. Thus it is classified as a Director’s Dealing report (DIRS).
2026-04-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean disclosure titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” which translates to a report on specific securities ownership for executives and major shareholders. It details individual trades, holdings before and after transactions, and purchase dates. This matches the definition of insider trading or director’s dealing disclosures (Code: DIRS).
2026-04-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” detailing an officer’s (윤종필) ownership and transaction history of company shares, including trade dates, quantities, and prices. This matches the definition of insider share transactions by directors/executives. Therefore, it falls under Director’s Dealing (Code: DIRS).
2026-04-23 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice summoning shareholders to the 28th Extraordinary General Meeting, detailing date, venue, agenda resolutions (including bylaw amendments, share repurchase plan, executive compensation rules), electronic voting/proxy procedures, and accompanying disclosure items. It is not a full annual or quarterly report, nor is it an earnings release or regulatory announcement of results. Instead, it is the meeting notice and proxy solicitation materials sent to shareholders to inform them of agenda items and request their votes. This aligns with the “Proxy Solicitation & Information Statement” category (PSI).
2026-04-22 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled “의결권대리행사권유참고서류,” which in Korean means proxy solicitation reference materials. It provides detailed information on proxy voting, proxy agents, meeting date, agenda items, and amendments to the articles of incorporation. This aligns exactly with a Proxy Solicitation & Information Statement, not an earnings release, annual report, or regulatory announcement. Therefore, it should be classified as PSI.
2026-04-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.